EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Benralizumab Reduces Respiratory Exacerbations and Oral Glucocorticosteroid Dose in Patients with Severe Asthma and Eosinophilic Granulomatosis with Polyangiitis

Carlo Mümmler iD, Pontus Mertsch, Michaela Barnikel iD, Frank Haubner, Ulf Schönermarck, Ulrich Grabmaier, Hendrik Schulze-Koops, Jürgen Behr iD, Nikolaus Kneidinger iD, Katrin Milger iD

Journal of Asthma and Allergy · 2024-06 · Volume 17 · 557-572

DOI: 10.2147/jaa.s461800 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Asthma and Allergy, 2024-06. Verfasst von Carlo Mümmler und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine V, LMU University Hospital, LMU Munich, Comprehensive Pneumology Center, Member of the German Center of Lung Research (DZL), M…. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

CRSEGPAOCSanti-IL5Rasthmabenralizumabbiologicsglucocorticoidvasculitis

Autor:innen und Institutionen

  • Department of Medicine V, LMU University Hospital, LMU Munich, Comprehensive Pneumology Center, Member of the German Center of Lung Research (DZL), Munich, Germany.
  • Department of Otorhinolaryngology, LMU University Hospital, LMU Munich, Munich, Germany.
  • Division of Nephrology, Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.
  • Department of Medicine I, LMU University Hospital, LMU Munich, Munich, Germany.
  • Division of Rheumatology and Clinical Immunology, Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.
  • Division of Pulmonology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.

ORCID-Profile: Carlo Mümmler, Michaela Barnikel, Jürgen Behr, Nikolaus Kneidinger, Katrin Milger

Zitieren

APA

Mümmler, C., Mertsch, P., Barnikel, M., Haubner, F., Schönermarck, U., Grabmaier, U., Schulze-Koops, H., Behr, J., Kneidinger, N., & Milger, K. (2024). Benralizumab Reduces Respiratory Exacerbations and Oral Glucocorticosteroid Dose in Patients with Severe Asthma and Eosinophilic Granulomatosis with Polyangiitis. Journal of Asthma and Allergy, Volume 17, 557-572. https://doi.org/10.2147/jaa.s461800

Vancouver

Mümmler C, Mertsch P, Barnikel M, Haubner F, Schönermarck U, Grabmaier U, et al. Benralizumab Reduces Respiratory Exacerbations and Oral Glucocorticosteroid Dose in Patients with Severe Asthma and Eosinophilic Granulomatosis with Polyangiitis. Journal of Asthma and Allergy. 2024;Volume 17:557-572. doi:10.2147/jaa.s461800

BibTeX
@article{Mmmler2024,
  author = {Mümmler, Carlo and Mertsch, Pontus and Barnikel, Michaela and Haubner, Frank and Schönermarck, Ulf and Grabmaier, Ulrich and Schulze-Koops, Hendrik and Behr, Jürgen and Kneidinger, Nikolaus and Milger, Katrin},
  title = {Benralizumab Reduces Respiratory Exacerbations and Oral Glucocorticosteroid Dose in Patients with Severe Asthma and Eosinophilic Granulomatosis with Polyangiitis},
  journal = {Journal of Asthma and Allergy},
  year = {2024},
  volume = {Volume 17},
  pages = {557--572},
  doi = {10.2147/jaa.s461800}
}
Kostenlos starten →